Title:
チモーゲンを含む一成分フィブリン糊
Document Type and Number:
Japanese Patent JP6866160
Kind Code:
B2
Abstract:
Provided herein is a single component sealant formulation (e.g. in a liquid form), methods for its preparation, and use. The formulation includes fibrinogen; vitamin K-dependent clotting zymogens comprising at least Factor II (FII) and Factor X (FX).
More Like This:
Inventors:
Pilper Yale
DeAngris Ashley
Zeldev Yuri
Delon Shebang
GORMAN, Anne, J.
Null Israel
DeAngris Ashley
Zeldev Yuri
Delon Shebang
GORMAN, Anne, J.
Null Israel
Application Number:
JP2016542705A
Publication Date:
April 28, 2021
Filing Date:
December 04, 2014
Export Citation:
Assignee:
Omrix Biopharmaceuticals Ltd.
Ethicon, Inc.
Ethicon, Inc.
International Classes:
A61L15/00; A61K9/08; A61K38/36; A61K47/02; A61K47/12; A61K47/18; A61K47/36; A61P7/04; A61P41/00
Domestic Patent References:
| JP2002514948A | ||||
| JP2001524953A | ||||
| JP2005239613A |
Foreign References:
| US20050192222 |
Other References:
Thromb. Res., 1994, Vol.76, No.6, pp.525-533
Clin. Appl. Thromb. Hemost., 2007, Vol.13, No.2, pp.146-153
Clin. Appl. Thromb. Hemost., 2007, Vol.13, No.2, pp.146-153
Attorney, Agent or Firm:
Konobu Kato